IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q1 2016 Holdings

Filed 2016-05-16 | 13 holdings | $110.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Edge Therapeutics IncCOM279870109$21.5K2,344,86819.4%
Versartis IncCOM92529L102$16.4K2,039,22314.8%
Dimension Therapeutics IncCOM25433V105$16.1K2,059,28314.6%
Oxford Immunotec Global PLCORD SHSG6855A103$13.7K1,377,49712.4%
Wave Life Sciences LTD(WVE)SHSY95308105$10.9K784,1599.9%
Dynavax Technologies Corp(DVAX)COM NEW268158201$9.5K496,0428.6%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$6.1K247,8065.5%
Sage Therapeutics Inc(SG7)COM78667J108$4.6K142,5704.1%
Dermira Inc(DERMEUR)COM24983L104$3.8K183,8843.4%
Marinus Pharmaceuticals IncCOM56854Q101$3.8K704,5723.4%
Chimerix Inc(CMRXEUR)COM16934W106$3.0K582,9042.7%
Incyte Corp(INCY)COM45337C102$1.2K16,0001.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$10912,2260.1%